Evgeny V. Levchenko
68 Leningradskaya Street
Saint Petersburg, SPE 197758, Russian Federation
Saint Petersburg, SPE 197758, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Lung Chemoperfusion Improves Relapse-Free Survival after Metastasectomy for Colorectal Cancer.
Journal: The Thoracic and cardiovascular surgeon
Published: July 11, 2025
Evaluation of Risk Factors for Early Insufficiency after Bronchial Sleeve Resections.
Journal: The Thoracic and cardiovascular surgeon
Published: August 08, 2024
Y-type carinal reconstruction after sleeve right lower bilobectomy.
Journal: JTCVS techniques
Published: March 29, 2024
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
Journal: JAMA oncology
Published: June 04, 2021
Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation.
Journal: Expert opinion on pharmacotherapy
Published: September 04, 2020
Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives.
Journal: Critical reviews in oncology/hematology
Published: August 06, 2020
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 14, 2019
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
Journal: The New England journal of medicine
Published: June 06, 2019
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 10, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.
Journal: Investigational new drugs
Published: March 10, 2019
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: December 19, 2017
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 16, 2017
Last Updated: 09/26/2026